Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Two Part question for the list

Two Part question for the list

posted on Jan 17, 2008 03:34PM

Considering the important milestone that the "business resolutions" to the Texas litigation represent, is the company currently working diligently on resolving any accounting questions regarding the reporting of these settlements and the other license deals from this quarter so that at the end of the quarter, the financials can be filed in a timely manner. 

Additionally, considering the market's strong negative reaction to the absence of any information regarding these settlements, and in an effort to demonstrate a proactive and genuine interest in protecting the PTSC shareholders interests, will you as CEO of PTSC, commit to having the PTSC 10q for the quarter ending February 28, filed within two weeks from the end of the quarter, rather than waiting till the very last days of the allowable filing timeframe as has been common place in recent years.

Share
New Message
Please login to post a reply